Skip to content

To study different mutations in filaggrin gene and their correlation with clinical and laboratory parameters in adults having atopic dermatitis

To study the frequency of selected filaggrin mutations and their correlation with clinicodemographic and laboratory parameters in adults having atopic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/032308
Enrollment
138
Registered
2021-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L208- Other atopic dermatitis

Interventions

None listed

Sponsors

Anuradha Bishnoi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age at presentation more than 18 years Active atopic dermatitis, diagnosis of which shall be made on 2 grounds: 1. Fulfillment of Hanifin and Rajka’s original criteria, and 2. Expert opinion where 3 independent eczema experts shall decide whether or not a patient has atopic dermatitis and the cases where all the experts decide unanimously on the diagnosis shall be recruited in the present study. Willing to undergo filaggrin mutation status assessment, serum IgE levels (total and specific) and patch testing with atopic patch tests and standard patch testing with Indian standard series.

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Any immunocompromised state Isolated hand eczema in absence of any other lesions of atopic dermatitis on body.

Design outcomes

Primary

MeasureTime frame
To assess the frequency of selected filaggrin mutations in adults having atopic dermatitis.Timepoint: Baseline only

Secondary

MeasureTime frame
To see whether the presence of any of these mutations in adults having atopic dermatitis has a correlation with 1. Age of onset of eczema (pediatric-onset vs adult-onset AD) and its duration 2. Severity of eczema at presentation 3. Levels of total and specific serum IgE levels at presentation 4. Results of atopy patch tests and standard patch tests carried out with Indian standard series. Timepoint: Baseline only

Countries

India

Contacts

Public ContactAnuradha Bishnoi

Department of Dermatology, PGIMER, Chandigarh

dranha14@gmail.com8872348999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026